CClinicalTrials.gg
CompletedNCT05817968Updated May 2, 2024

Solid State vs. Balloon Esophageal Catheter for Estimation of Pleural Pressure

An interventional study of intelligent Esophageal Pressure Catheter (iEPC) in Respiratory Failure and Mechanical Ventilation, sponsored by Erasmus Medical Center. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-02.

Sponsored by Erasmus Medical Center · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Measurements of esophageal pressure (Pes) as surrogate for pleural pressure are routinely performed in selected ICU patients to facilitate lung-protective ventilation and assess breathing effort. Pes is clinically measured via a nasogastric esophageal catheter. Current techniques involve balloon catheters but have some important disadvantages as they could deflate over time and require a very precise positioning and filling volume. A solid-state sensor does not have disadvantages associated with balloon catheters and may therefore be a useful alternative in clinical practice.

This method-comparison study in adult mechanically ventilated ICU patients evaluates the accuracy of Pes measured using an esophageal catheter with a solid-state sensor as compared to a balloon catheter as reference standard.

Read the detailed description

Measurements of esophageal pressure (Pes) as surrogate for pleural pressure are routinely performed in selected ICU patients to facilitate lung-protective ventilation and assess breathing effort. Pes is clinically measured via a nasogastric esophageal catheter. Current techniques involve balloon catheters but have some important disadvantages as they could deflate over time and require a very precise positioning and filling volume. A solid state sensor does not have disadvantages associated with balloon catheters and may therefore be a useful alternative in clinical practice.

This method-comparison study in adult mechanically ventilated ICU patients evaluates the accuracy of Pes measured using an esophageal catheter with a solid-state sensor as compared to a balloon catheter as reference standard.

Subjects will receive a standard balloon esophageal catheter and a solid-state pressure catheter for simultaneous measurements of Pes. Study population will be post-surgical ICU patients. Measurements will be performed during clinical mechanical ventilation settings which include a first phase of passive controlled ventilation (patient is still sedated after surgery) as well a phase of partially-assisted ventilation where the patient's breathing effort has resumed and is assisted by the ventilator. During both phases, 10-15 minutes of tidal breathing will be recorded.

02

Conditions studied

  • Respiratory Failure
  • Mechanical Ventilation

Keywords

  • Esophageal manometry
  • Respiratory monitoring
  • Mechanical ventilation
  • Pleural pressure
03

In context

Respiratory Insufficiency

1,650 studies on the registry are indexed under Respiratory Insufficiency; 296 are open to participants now.

This study's enrollment of 16 is below the median of 55 across 1,043 interventional studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

Erasmus Medical Center is the lead sponsor of 466 studies on the registry; 179 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Signed informed consent
  • Patient requiring mechanical ventilation at the ICU following cardiothoracic or abdominal surgery
  • Age ≥ 18 year

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Upper airway/esophageal/mouth or face pathology (i.e. recent surgery, esophageal varices, diaphragmatic hernia)
  • Nasal bleeding within the last \<2 weeks
  • Presence of pneumothorax
  • Use of anticoagulants that increase the risk of catheter insertion
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Esophageal manometry using a solid state sensor vs. balloon catheter

    Placement of both a solid state and balloon esophageal pressure (Pes) catheter. Pes recordings of these catheters will be acquired simultaneously during both controlled mechanical ventilation and assisted mechanical ventilation, for 10-15 minutes per phase. Ventilator settings/protocol will be as per standard-of-care.

    Device: intelligent Esophageal Pressure Catheter (iEPC)

Interventions

  • Deviceintelligent Esophageal Pressure Catheter (iEPC)

    Placement of the iEPC nasogastric catheter with solid state sensor for esophageal manometry. Comparator: Esophageal balloon catheter (NutriVent).

    Also known as: Solid state esophageal pressure catheter, PulmoTech B.V.

06

What researchers measure

Primary outcomes

  1. Difference in absolute Pes-derived parameters obtained by solid state catheter vs. balloon catheter.

    Absolute Pes value (in cmH2O) at end-expiration and at peak inspiration (based on flow recordings) will be recorded.

    Time frame: 30 minutes

  2. Difference in relative Pes-derived parameters obtained by solid state catheter vs. balloon catheter.

    Relative Pes value (cmH2O) will be measured as the inspiratory amplitude in Pes.

    Time frame: 30 minutes

07

Study locations

1 site
  • Erasmus MC
    Rotterdam, Zuid-Holland 3015GD, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05817968
Lead sponsor
Erasmus Medical Center
Collaborators
Pulmotech B.V.
Responsible party
Annemijn Jonkman (Assistant Professor, Erasmus Medical Center) — Principal investigator
First posted
Apr 18, 2023
Start date
Oct 20, 2023
Primary completion
Mar 21, 2024
Completion
Mar 21, 2024
Last update
May 2, 2024

Study contacts

Annemijn Jonkman, PhD
principal investigator · Erasmus Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion